无线电技术
医学
多中心研究
癌症
肿瘤科
内科学
转录组
DNA错配修复
放射科
生物信息学
梅德林
精密医学
总体生存率
作者
Siwei Pan,Enze Li,Guoliang Zheng,Yi You,Yanqiang Zhang,Mengxuan Cao,Ruolan Zhang,Qing Yang,Yizhou Wei,Weiwei Zhu,Ke Shen,Chencui Huang,Jingxu Xu,Lijing Wang,Zaisheng Cai,Zhiyuan Xu,Can Hu
标识
DOI:10.20892/j.issn.2095-3941.2025.0254
摘要
Gastric cancer (GC) remains a major global health challenge, because of its poor prognosis and limited treatment options in advanced stages[1][1],[2][2]. Recent advancements in immunotherapy, highlighted by the findings of the CHECKMATE-649, ORIENT-16, and KEYNOTE-859 trials, have markedly
科研通智能强力驱动
Strongly Powered by AbleSci AI